Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...

BioSymetrics is a leading AI-powered drug discovery and data analytics company, focusing on phenotype-based insights to ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) ...

Improving early detection is one of several holy grails in pancreatic cancer research. Many believe biomarkers — biological ...

This new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...

A research team at the Institute of Nano Science and Technology (INST), Mohali has identified a common biomarker for early ...

Research into improving the detection of ovarian cancer is set to get a boost thanks to funding from the Cancer Society.

SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...

Medical Dialogues team interacts with the lead author of a recent research titled- Lung cancer screening in India: Preparing ...